PlotkinSA, FarquharJD, and OgraPL: Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA, 1973; 225:585–590.
2.
WiktorTJ, PlotkinSA, and KoprowskiH: Development and clinical trials of the new human rabies vaccine of tissue culture (human diploid cell) origin. Devel Biol Stand, 1978; 40:3–9.
3.
HackettCJ, SullivanK, and LinYL: Ultrastructure of an influenza virus-specific cytotoxic T-cell clone and its interaction with P815 and macrophage targets. Cell Immunol, 1982; 68:276–286.
4.
GerhardW, HackettC, and MelchersF: The recognition specificity of a murine helper T cell for hemagglutinin of influenza virus A/PR/8/34. J Immunol, 1983; 130:2379–2385.
5.
MillsKH, SkehelJJ, and ThomasDB: Conformational-dependent recognition of influenza virus hemagglutinin by murine T helper clones. Eur J Immunol, 1986; 16:276–280.
6.
HackettCJ, DietzscholdB, GerhardW, GhristB, KnorrR, GillessenD, and MelchersF: Influenza virus site recognized by a murine helper T cell specific for H1 strains. Localization to a nine amino acid sequence in the hemagglutinin molecule. J Exp Med, 1983; 158:294–302.
7.
TownsendAR, RothbardJ, GotchFM, BahadurG, WraithD, and McMichaelAJ: The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell, 1986; 44:959–968.
8.
HurwitzJL, Herber-KatzE, HackettCJ, and GerhardW: Characterization of the murine TH response to influenza virus hemagglutinin: evidence for three major specificities. J Immunol, 1984; 133:3371–3377.
9.
GerhardW, HabermanAM, ScherlePA, TaylorAH, PalladinoG, and CatonAJ: Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice. J Virol, 1991; 65:364–372.
10.
WysockaM, EisenlohrLC, OtvosLJr, HorowitzD, YewdellJW, BenninkJR, and HackettCJ: Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation. Virology, 1994; 201:86–94.
11.
HurwitzJL, HackettCJ, McAndrewEC, and GerhardW: Murine TH response to influenza virus: recognition of hemagglutinin, neuraminidase, matrix, and nucleoproteins. J Immunol, 1985; 134:1994–1998.
12.
HackettCJ, HorowitzD, WysockaM, and DillonSB: Influenza virus infection elicits class II major histocompatibility complex-restricted T cells specific for an epitope identified in the NS1 non-structural protein. J Gen Virol, 1992; 73(Pt 6):1339–1343.
13.
RileyMP, CerasoliDM, JordanMS, PetroneAL, ShihFF, and CatonAJ: Graded deletion and virus-induced activation of autoreactive CD4+ T cells. J Immunol, 2000; 165:4870–4876.
14.
EisenlohrLC, and HackettCJ: Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis. J Exp Med, 1989; 169:921–931.
